V-0219
V-0219 (Compound 9) is an orally active, positive allosteric modulator (PAM) of the glucagon-like peptide-1 receptor (GLP-1R) . V-0219 can be used for obesity-associated diabetes research[1].
Product Specifications
UNSPSC
12352005
Target
GLP Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/v-0219.html
Concentration
10mM
Purity
99.90
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
FC(C1=CC=C(C2=NOC(CN3CC(CN4CCOCC4)CCC3)=N2)C=C1)(F)F
Molecular Formula
C20H25F3N4O2
Molecular Weight
410.43
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-143312/V-0219-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-143312/V-0219-SDS-MedChemExpress.pdf
Scientific Category
Reference compound1
Clinical Information
No Development Reported
CAS Number
[878453-71-5]
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Recombinant Gloydius brevicaudus siniticus Phospholipase A2 inhibitor subunit B
Recombinant Gloydius brevicaudus siniticus Phospholipase A2 inhibitor subunit B
Recombinant Gloydius brevicaudus siniticus Phospholipase A2 inhibitor subunit B
Recombinant Gloydius brevicaudus siniticus Phospholipase A2 inhibitor subunit B
Recombinant Gloydius brevicaudus siniticus Phospholipase A2 inhibitor subunit B